Other Vascular Disorders

  • Thomas H. Williamson
Chapter

Abstract

There are a number of conditions which stimulate neovascularisation of the retina with subsequent complications such as vitreous haemorrhage and tractional retinal detachment from pathological separation of the vitreous. The most common is severe diabetic retinopathy but also retinal vein occlusion, sickle-cell retinopathy and retinal vasculitis.

Keywords

Macular Hole Retinal Vein Occlusion Cystoid Macular Oedema Vitreous Haemorrhage Central Retinal Vein Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Supplementary material

haemorrhage and trd (426,050 KB)

References

  1. Alldredge CD, Garretson BR (2003) Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 23(1):113–116PubMedCrossRefGoogle Scholar
  2. Antcliff RJ, Spalton DJ, Stanford MR et al (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108(4):765–772PubMedCrossRefGoogle Scholar
  3. Benhamou N, Massin P, Haouchine B et al (2003) Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135(2):246–249PubMedCrossRefGoogle Scholar
  4. Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular oedema in branch vein occlusion. Am J Ophthalmol 98:271–282Google Scholar
  5. Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRefGoogle Scholar
  6. Brazier DJ, Gregor ZJ, Blach RK et al (1986) Retinal detachment in patients with proliferative sickle cell retinopathy. Trans Ophthalmol Soc UK 105((Pt 1)):100–105PubMedGoogle Scholar
  7. Browning DJ, Antoszyk AN (1998) Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 105(4):670–677PubMedCrossRefGoogle Scholar
  8. Bynoe LA, Weiss JN (2003) Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 135(3):382–384PubMedCrossRefGoogle Scholar
  9. Clarkson JG (1992) The ocular manifestations of sickle-cell disease: a prevalence and natural history study. Trans Am Ophthalmol Soc 90:481–504PubMedGoogle Scholar
  10. Cohen SB, Fletcher ME, Goldberg MF, Jednock NJ (1986) Diagnosis and management of ocular complications of sickle hemoglobinopathies: part V. Ophthalmic Surg 17(6):369–374PubMedGoogle Scholar
  11. Condon P, Jampol LM, Farber MD et al (1984) A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. II. Update and analysis of risk factors. Ophthalmology 91(12):1496–1498PubMedGoogle Scholar
  12. Conway MD, Canakis C, Livir-Rallatos C, Peyman GA (2003) Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg 29(1):27–33PubMedCrossRefGoogle Scholar
  13. Cringle SJ, Yu DY, Alder VA (1992) Intravitreal and intraretinal oxygen tension in the rat eye. Afv Exp Med Biol 316:113–117CrossRefGoogle Scholar
  14. Degenring RF, Jonas JB (2003) Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 87(3):361PubMedCrossRefGoogle Scholar
  15. Degenring RF, Kamppeter B, Kreissig I, Jonas JB (2003) Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol Scand 81(4):399–401PubMedCrossRefGoogle Scholar
  16. Downes SM, Hambleton IR, Chuang EL et al (2005) Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. Ophthalmology 112(11):1869–1875PubMedCrossRefGoogle Scholar
  17. Fox PD, Minninger K, Forshaw ML et al (1993) Laser photocoagulation for proliferative retinopathy in sickle haemoglobin C disease. Eye 7(Pt 5):703–706PubMedCrossRefGoogle Scholar
  18. Fujii GY, De Juan E Jr, Humayan MS (2003) Improvements after sheathotomy for branch retinal vein occlusion documented by optical coherence tomography and scanning laser ophthalmoscope. Opthalmic Surg Lasers Imaging 34:49–52Google Scholar
  19. Garcia-Arumi J, Boixadera A, Martinez-Castillo V et al (2003) Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 121(10):1385–1391CrossRefGoogle Scholar
  20. Garcia-Arumi J, Martinez-Castillo V, Boixadera A et al (2006) Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol 90(10):1252–1255PubMedCrossRefGoogle Scholar
  21. Goldberg MF (1971) Classification and pathogenesis of proliferative sickle retinopathy. Am J Ophthalmol 71(3):649–665PubMedGoogle Scholar
  22. Green WR, Chan CC, Hutchins GM, Terry JM (1981) Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79:371–422PubMedGoogle Scholar
  23. Greenberg PB, Martidis A, Rogers AH et al (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86(2):247–248PubMedCrossRefGoogle Scholar
  24. Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117(6):1134–1146.e3PubMedCrossRefGoogle Scholar
  25. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132(3):425–427PubMedCrossRefGoogle Scholar
  26. Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240(9):782–783PubMedCrossRefGoogle Scholar
  27. Jonas JB, Kreissig I, Degenring RF (2003) Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 136(2):384–386PubMedCrossRefGoogle Scholar
  28. Jonas JB, Harder B, Kamppeter BA (2004) Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 138(6):970–977PubMedCrossRefGoogle Scholar
  29. Jonas JB, Akkoyun I, Kamppeter B et al (2005a) Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19(1):65–71PubMedCrossRefGoogle Scholar
  30. Jonas JB, Akkoyun I, Kreissig I, Degenring RF (2005b) Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. Br J Ophthalmol 89(3):321–326PubMedCrossRefGoogle Scholar
  31. Martidis A, Duker JS, Puliafito CA (2001) Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 119(9):1380–1383PubMedGoogle Scholar
  32. Martidis A, Duker JS, Greenberg PB et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109(5):920–927PubMedCrossRefGoogle Scholar
  33. Mason J III, Feist R, White M Jr et al (2004) Sheathotomy to decompress branch retinal vein occlusion: a matched control study. Ophthalmology 111(3):540–545PubMedCrossRefGoogle Scholar
  34. McAllister IL, Constable IJ (1995) Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein ­occlusion. Arch Ophthalmol 113(4):456–462PubMedCrossRefGoogle Scholar
  35. McAllister IL, Douglas JP, Constable IJ, Yu DY (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk ­factors. Am J Ophthalmol 126(2):219–229PubMedCrossRefGoogle Scholar
  36. Opremcak EM, Bruce RA (1999) Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 19(1):1–5PubMedCrossRefGoogle Scholar
  37. Opremcak EM, Bruce RA, Lomeo MD et al (2001) Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 21(5):408–415PubMedCrossRefGoogle Scholar
  38. Opremcak EM, Rehmar AJ, Ridenour CD et al (2006) Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina 26(3):306–313PubMedCrossRefGoogle Scholar
  39. Osterloh MD, Charles S (1988) Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 106:1469–1471PubMedCrossRefGoogle Scholar
  40. Platt OS, Brambilla DJ, Rosse WF et al (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330(23):1639–1644PubMedCrossRefGoogle Scholar
  41. Saika S, Tanaka T, Miyamoto T, Ohnishi Y (2001) Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239(10):729–732PubMedCrossRefGoogle Scholar
  42. Spandau UH, Derse M, Schmitz-Valckenberg P et al (2005) Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema. Br J Ophthalmol 89(8):999–1003PubMedCrossRefGoogle Scholar
  43. The Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115(4):486–491CrossRefGoogle Scholar
  44. Weiss JN (1998) Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 126(1):142–144PubMedCrossRefGoogle Scholar
  45. Weiss JN, Bynoe LA (2001) Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108(12):2249–2257PubMedCrossRefGoogle Scholar
  46. Williamson TH, O’Donnell A (2005) Intravitreal triamcinolone ­acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 139(5):860–866PubMedCrossRefGoogle Scholar
  47. Williamson TH, Poon W, Whitefield L et al (2003) A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ­ischaemic central retinal vein occlusion. Br J Ophthalmol 87(9):1126–1129PubMedCrossRefGoogle Scholar
  48. Williamson TH, Grewal J, Gupta B et al (2009a) Measurement of PO2 during vitrectomy for central retinal vein occlusion, a pilot study. Graefes Arch Clin Exp Ophthalmol 247(8):1019–1023PubMedCrossRefGoogle Scholar
  49. Williamson TH, Rajput R, Laidlaw DA, Mokete B (2009b) Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy. Eye 23(6):1314–1320PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Thomas H. Williamson
    • 1
  1. 1.Department of OphthalmologySt. Thomas’ HospitalLondonUK

Personalised recommendations